A pregnant patient at 30 weeks gestation presents with elevated blood pressure, proteinuria, and neurological irritability. Which of the following is the most appropriate initial nursing intervention to prevent complications associated with her condition?

B) Implement seizure precautions and monitor for signs of eclampsia.

A) Encourage the patient to increase her fluid intake to reduce proteinuria.

B) Implement seizure precautions and monitor for signs of eclampsia.

C) Advise the patient to rest in a supine position to lower blood pressure.

D) Administer a diuretic as prescribed to manage hypertension.

A 30-week pregnant patient presents with elevated blood pressure, proteinuria, and brisk reflexes with clonus. Which immediate nursing intervention is most appropriate to address the potential progression to severe preeclampsia?

C) Administer intravenous magnesium sulfate

A) Initiate continuous electronic fetal monitoring

B) Prepare the patient for an immediate cesarean delivery

C) Administer intravenous magnesium sulfate

D) Increase oral fluid intake to improve hydration status

A 30-week pregnant patient has been diagnosed with preeclampsia with mild features. The healthcare team decided to administer antenatal corticosteroids. What is the primary rationale for giving corticosteroids in this scenario?

B) To enhance fetal lung maturity in preparation for possible early delivery

A) To reduce maternal blood pressure and prevent seizures

B) To enhance fetal lung maturity in preparation for possible early delivery

C) To decrease proteinuria and improve liver function

D) To increase platelet count and address thrombocytopenia

A 30-week gestation pregnant patient has been diagnosed with preeclampsia with mild features. Which of the following actions should the nurse prioritize to ensure both maternal and fetal well-being?

B) Administer antihypertensive medication and monitor fetal heart rate patterns.

A) Educate the patient on the importance of bed rest and monitor for signs of severe preeclampsia.

B) Administer antihypertensive medication and monitor fetal heart rate patterns.

C) Schedule weekly ultrasounds to assess fetal growth and administer magnesium sulfate for neuroprotection.

D) Encourage the patient to increase fluid intake and perform daily fetal kick counts.

A pregnant patient at 32 weeks gestation presents with severe headache, visual disturbances, BP of 164/110 mmHg, elevated liver enzymes, and thrombocytopenia. The healthcare team considers expediting delivery. What is the immediate nursing priority for this patient?

C) Initiate magnesium sulfate infusion

A) Administer oral antihypertensive medication

B) Prepare the patient for potential cesarean delivery

C) Initiate magnesium sulfate infusion

D) Monitor fetal heart rate continuously

A pregnant patient at 32 weeks gestation is admitted with severe preeclampsia. The healthcare team is considering an expedited delivery. Which nursing intervention should be prioritized to stabilize the patient's condition and prevent further complications?

B) Initiate intravenous magnesium sulfate therapy to prevent seizures.

A) Administer oral antihypertensive medication to control blood pressure.

B) Initiate intravenous magnesium sulfate therapy to prevent seizures.

C) Prepare the patient for immediate cesarean delivery without further stabilization.

D) Encourage the patient to rest and monitor vital signs every four hours.

A pregnant patient is admitted to the obstetric unit with severe preeclampsia. Her symptoms include a severe headache, visual disturbances, high blood pressure, and upper right quadrant tenderness. Fetal heart rate monitoring shows late decelerations, and ultrasound reveals oligohydramnios. Which nursing intervention should take priority in this situation?

C) Prepare the patient for an immediate cesarean delivery

A) Administer a magnesium sulfate infusion to prevent seizures

B) Increase the rate of IV fluids to improve fetal circulation

C) Prepare the patient for an immediate cesarean delivery

D) Administer a second dose of intravenous labetalol to manage hypertension

A pregnant patient with severe preeclampsia is admitted to the obstetric unit with a persistent severe headache, increasing vision difficulties, high blood pressure, and right upper quadrant tenderness. Fetal monitoring shows late decelerations, and the biophysical profile score is 6/10. What is the most appropriate nursing action to prioritize at this time?

C) Prepare the patient for an immediate cesarean delivery

A) Administer a dose of magnesium sulfate to prevent seizures

B) Increase the infusion rate of intravenous labetalol to lower blood pressure

C) Prepare the patient for an immediate cesarean delivery

D) Provide the patient with oxygen via face mask to improve fetal oxygenation

A patient with HELLP syndrome is scheduled for an urgent cesarean section due to worsening maternal and fetal conditions. What is the priority nursing intervention to prepare for the procedure?

D) Ensure intravenous access with a large-bore catheter and prepare emergency medications.

A) Administer platelet transfusion to prevent bleeding complications.

B) Initiate continuous fetal monitoring to assess fetal well-being.

C) Educate the patient and family about the risks of general anesthesia.

D) Ensure intravenous access with a large-bore catheter and prepare emergency medications.

A pregnant patient with HELLP syndrome is scheduled for an emergency cesarean section under general anesthesia due to worsening maternal and fetal conditions. Which nursing intervention is the priority to minimize the risk of complications during this procedure?

D) Prepare and administer magnesium sulfate to prevent seizures.

A) Administer a platelet transfusion before the procedure.

B) Ensure continuous fetal heart rate monitoring until anesthesia is administered.

C) Position the patient in the left lateral position to optimize uteroplacental blood flow.

D) Prepare and administer magnesium sulfate to prevent seizures.

preganncy - Nursing Case Study

Pathophysiology

• Primary mechanism: Hormonal changes - Pregnancy initiates significant hormonal shifts, primarily the increase in human chorionic gonadotropin (hCG), progesterone, and estrogen, which maintain the uterine lining and support fetal development.

• Secondary mechanism: Cardiovascular adaptations - Blood volume expands by 30-50%, and cardiac output increases to supply adequate oxygen and nutrients to the fetus, often leading to changes in blood pressure and heart rate.

• Key complication: Gestational hypertension - This condition can arise from the increased cardiovascular demands and may lead to preeclampsia if not monitored, necessitating careful blood pressure management to prevent adverse maternal and fetal outcomes.

Patient Profile

Demographics:

32-year-old female, office manager

History:

• Key past medical history: Gestational diabetes in previous pregnancy, mild hypertension

• Current medications: Prenatal vitamins, Labetalol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and swelling in the hands and feet

• Key symptoms: Blurred vision, fatigue, increasing shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

Initial Assessment Findings:

Upon further assessment, the nursing team noted additional concerning symptoms and physical findings. The patient's reflexes were brisk, with a patellar reflex score of 3+, indicating heightened neuromuscular response. There was also noted clonus in the ankle, which could suggest neurological irritability. Her urine dipstick test revealed proteinuria with a reading of 2+, raising concerns for possible preeclampsia given her history of hypertension and current presentation. Additionally, the fundal height was measured to be approximately 29 centimeters, consistent with her gestational age of 30 weeks, suggesting normal fetal growth despite maternal complications.

The patient's blood pressure, upon repeat measurement, remained elevated at 152/98 mmHg. This sustained hypertension, coupled with the proteinuria and neurological findings, pointed toward a potential progression from gestational hypertension to preeclampsia. Given these findings, the clinical team prioritized further diagnostic evaluations to confirm the diagnosis and assess the severity of the condition. This included ordering a complete blood count (CBC), liver function tests, and a 24-hour urine collection to quantify proteinuria more accurately.

These assessments underscored the importance of timely intervention to prevent the potential escalation to severe preeclampsia or eclampsia. The healthcare team was tasked with initiating a treatment plan that may involve antihypertensive therapy adjustments and potentially considering antenatal corticosteroids to accelerate fetal lung maturity if early delivery becomes necessary. The clinical reasoning at this juncture was pivotal in balancing the risks of maternal complications against fetal maturity, guiding the next steps in managing the patient's care.

Section 2

New Diagnostic Results:

Following the initial assessments, the results from the additional diagnostic tests provided further insights into the patient's condition. The complete blood count (CBC) revealed a hematocrit of 36%, within normal limits, but there was a mild thrombocytopenia with platelet levels at 120,000/mm³, slightly below the normal range. Liver function tests indicated elevated liver enzymes, with an AST of 48 U/L and ALT of 52 U/L, suggesting some hepatic involvement, which could be consistent with preeclampsia. The 24-hour urine collection confirmed significant proteinuria, with a total protein excretion of 1.5 grams, reinforcing the suspicion of preeclampsia.

These findings prompted the healthcare team to classify the patient's condition as preeclampsia with mild features, not yet progressing to severe preeclampsia but warranting close monitoring and intervention. The team discussed the importance of closely monitoring the patient's blood pressure and symptoms while starting on a low-dose aspirin and adjusting antihypertensive medications to better control her blood pressure. Additionally, since the patient was at 30 weeks of gestation, antenatal corticosteroids were administered to enhance fetal lung maturity in case early delivery became necessary.

The clinical reasoning at this point involved weighing the risks of continued pregnancy against the benefits of prolonging gestation to allow for further fetal development. The team emphasized the need for frequent reassessment of maternal and fetal status, including non-stress tests and biophysical profiles, to ensure timely intervention should the patient's condition deteriorate. This approach aimed to balance maternal and fetal health outcomes while preparing for potential complications that could arise as the pregnancy progressed.

Section 3

As the pregnancy progressed, the patient's condition required vigilant monitoring. During a routine follow-up, the patient presented with a new onset of severe headache and visual disturbances, both concerning signs potentially indicative of worsening preeclampsia. Vital signs revealed a blood pressure reading of 164/110 mmHg, significantly elevated from previous measurements, despite the current antihypertensive regimen. The clinical team immediately recognized these symptoms as potential indicators of progression to severe preeclampsia, necessitating urgent reevaluation of the management plan.

Further diagnostic tests were promptly conducted. Repeat liver function tests showed a further increase in liver enzymes, with AST and ALT rising to 72 U/L and 85 U/L, respectively. Additionally, a repeat CBC indicated a worsening of thrombocytopenia, with platelet levels dropping to 95,000/mm³. These findings, coupled with the patient's symptoms, suggested a potential development of severe preeclampsia or even HELLP syndrome, a serious complication requiring immediate intervention to prevent maternal and fetal morbidity.

In response to these changes, the healthcare team convened to discuss the necessity of expediting delivery to safeguard both maternal and fetal health. The patient was admitted for closer monitoring and stabilization, including intravenous antihypertensive therapy and magnesium sulfate to prevent seizures. Plans were made for a possible early delivery, with the obstetric team on standby. The focus shifted toward optimizing the timing of delivery, weighing the patient's rapidly evolving condition against the risks and benefits of continued gestation, and ensuring that all necessary preparations were in place for a safe delivery for both mother and baby.

Section 4

As the patient settled into the obstetric unit for closer monitoring, the healthcare team conducted an initial assessment to establish a baseline for her current status. The assessment revealed that the patient's severe headache persisted despite initial interventions, and she reported increasing difficulty in focusing her vision. Her blood pressure remained high, fluctuating between 160/108 mmHg and 168/112 mmHg, despite the administration of intravenous labetalol. Additionally, she exhibited mild upper right quadrant tenderness upon palpation, raising concerns about liver involvement indicative of HELLP syndrome progression. Fetal heart rate monitoring indicated a pattern of late decelerations, suggesting potential fetal distress, and necessitating immediate attention to the timing of delivery.

Given these concerning developments, the healthcare team prioritized further diagnostic testing to guide their management plan. A repeat urinalysis showed significant proteinuria with a reading of +3, confirming the progression of protein loss consistent with severe preeclampsia. A follow-up ultrasound was also conducted, which showed oligohydramnios, with amniotic fluid index reduced to 4 cm, further indicating compromised uteroplacental circulation. The biophysical profile scored at 6/10, reflecting fetal compromise, and underscoring the urgency of the situation.

In response to these findings, the clinical team discussed the need to expedite delivery, recognizing that the risks of continued gestation outweighed the potential benefits at this point. With the onset of new complications and the persistence of severe symptoms, it was determined that a cesarean delivery would provide the best outcome for both mother and child. Preparations were swiftly made, ensuring that neonatal care specialists were available to assist with potential complications related to preterm birth. The patient's medications were adjusted to stabilize her condition as much as possible before the procedure, and she was briefed on the plan to ensure her informed consent and understanding of the situation.

Section 5

As the team prepared for the cesarean delivery, the patient suddenly began to experience increased abdominal pain and a sense of overwhelming fatigue, prompting a rapid reassessment of her condition. Her blood pressure remained critically high at 172/115 mmHg despite ongoing antihypertensive treatment, heightening concerns about possible complications. Additionally, her lab results revealed a further decline in platelet count to 85,000/mm³, a significant rise in liver enzymes with AST at 90 U/L and ALT at 95 U/L, and worsening hemolysis as evidenced by elevated lactate dehydrogenase levels at 600 U/L. These findings confirmed the progression of HELLP syndrome, warranting immediate intervention.

Concurrently, fetal monitoring indicated worsening patterns with recurrent late decelerations and minimal variability, emphasizing the critical need for expedited delivery to prevent fetal compromise. The deterioration in both maternal and fetal statuses spurred the healthcare team to increase the urgency of the situation, ensuring that the operating room was prepared promptly. Anesthesia was consulted for optimal management of the impending cesarean section, considering the potential for coagulopathy due to the low platelet count. Given the patient's unstable condition, the decision was made to proceed with the cesarean section under general anesthesia to minimize the risk of bleeding complications associated with regional anesthesia.

Throughout this process, the team remained vigilant, closely monitoring the patient's vital signs and providing supportive care to stabilize her as much as possible. The collaborative efforts of the obstetricians, anesthesiologists, and neonatologists were crucial in orchestrating a coordinated approach to this high-risk situation. Each step was carefully communicated to the patient and her family, ensuring they were informed and prepared for the imminent delivery and the potential challenges that lay ahead. As they moved swiftly toward the operating room, the priority remained clear: to safely deliver the baby and stabilize the mother, addressing the immediate complications posed by the advanced HELLP syndrome.